InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,353.20
(
-0.32%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.08
(
-0.65%
)
Bitcoin
63,695.28
(
-0.89%
)
Post# of 470
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mick

Send PM Follow Ignore
Followers 3158
Posts 964110
Boards Moderated 196
Alias Born 09/04/2000

mick

Member Level

Re: None

Monday, 09/19/2016 10:41:08 AM

Monday, September 19, 2016 10:41:08 AM

Post# of 470
ARLZ News: Current Report Filing (8-k) 09/15/2016 10:58:37 AM
ARLZ News: Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients A... 09/15/2016 09:33:00 AM
ARLZ News: Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients A... 09/15/2016 09:33:00 AM
ARLZ News: Current Report Filing (8-k) 09/08/2016 10:37:19 AM
ARLZ News: Aralez Acquires United States And Canadian Rights To ZONTIVITY From Merck 09/07/2016 08:35:00 AM
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up